Transferability of the early-stage ovarian malignancy (EOM) score: an external validation study that includes advanced-stage and metastatic ovarian cancer.
Dumnoensun PruksakornJayanton PatumanondPanprapha SaenrungmuaengWatcharin ChirdchimTanyong PipanmekapornApichat TantraworasinTheera TongsongCharuwan TantipalakornPublished in: Archives of gynecology and obstetrics (2021)
The EOM score had consistent diagnostic performance in the external validation data. It is recommended for use as a triage tool in patient referrals instead of the RMI in settings where experienced sonographers are not available.